Role of MicroRNAs in Neuroendocrine Prostate Cancer
Therapy-induced neuroendocrine prostate cancer (t-NEPC/NEPC) is an aggressive variant of prostate cancer (PCa) that frequently emerges in castration-resistant prostate cancer (CRPC) under the selective pressure of androgen receptor (AR)-targeted therapies. This variant is extremely aggressive, metas...
Main Authors: | Amritha Sreekumar, Sharanjot Saini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Non-Coding RNA |
Subjects: | |
Online Access: | https://www.mdpi.com/2311-553X/8/2/25 |
Similar Items
-
The role of microRNAs in the pathogenesis, diagnosis and treatment of prostate cancer
by: M. Khorasani, et al.
Published: (2016-08-01) -
MicroRNAs in prostate cancer
by: Won Tae Kim, et al.
Published: (2013-03-01) -
Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
by: Amritha Sreekumar, et al.
Published: (2023-01-01) -
Mechanisms of castration resistant prostate cancer formation and progression through neuroendocrine differentiation
by: Xueping Ma, et al.
Published: (2021-09-01) -
Prostate‐derived circulating microRNAs add prognostic value to prostate cancer risk calculators
by: Morgan L. Zenner, et al.
Published: (2023-11-01)